Sign Up to like & get recommendations! 0
Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-90696-4
Abstract: Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) reduction. However, the mechanism of PG analogues is not completely… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2022.2071699
Abstract: ABSTRACT Background Vitiligo is a common cutaneous depigmentation disorder. Although multiple treatment options are available, no single modality is satisfactory for all patients. Several studies have demonstrated that prostaglandin analogues can potentially treat cutaneous depigmentation,… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.14669
Abstract: Due to immune‐mediated nature, medicines with immunomodulatory and anti‐inflammatory effects can used to treat many dermatologic diseases. Phosphodiesterase and prostaglandins are involved in many inflammatory pathways that cause cutaneous disorders. Phosphodiesterase inhibitors (PDEIs) and prostaglandin… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "BMC Ophthalmology"
DOI: 10.1186/s12886-021-02211-y
Abstract: Background To evaluate the effect of topical prostaglandin analogues on agreement of IOP measurements obtained by Goldmann applanation tonometry (GAT), rebound tonometry (RBT), and noncontact tonometry (NCT) in eyes with primary open- angle glaucoma (POAG).… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0239233
Abstract: Purpose This study aimed to review previous articles and evaluate the influence of topical non-steroidal anti-inflammatory drugs (NSAIDs) on intraocular pressure (IOP) in glaucoma patients who were treated with prostaglandin analogues (PGs). Method The presenting… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Vestnik oftalmologii"
DOI: 10.17116/oftalma2022138011107
Abstract: Prostaglandins are widely used in medicine as active physiological agents that form a new class of drugs for treatment of cardiovascular diseases, some forms of bronchial asthma, as well as in gynecology and ophthalmology. Development… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Vestnik oftalmologii"
DOI: 10.17116/oftalma2022138052285
Abstract: Currently, the only effective method of treatment and rehabilitation of patients with inactive thyroid eye disease (TED) is orbital decompression. This review analyzes the prospects of using prostaglandin analogues (PGF2β) to decrease the volume of… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Korean Journal of Ophthalmology : KJO"
DOI: 10.3341/kjo.2019.0129
Abstract: Purpose To evaluate the effects of each subgroup of prostaglandin analogues (PGAs) on central corneal thickness (CCT) in patients with normal tension glaucoma (NTG). Methods We retrospectively reviewed 55 eyes of 55 patients with NTG… read more here.